Search Results - "J. I. Herrero Herrero"

Medication errors detected in elderly patients admitted to an internal medicine service by García-Aparicio, J, Herrero-Herrero, J I

“…The aim of the work was to analyse the outpatient medication errors detected on admission in senior patients in a Spanish general internal medicine service. We…”
Get more information

Linezolid-Induced Lactic Acidosis in Two Liver Transplant Patients with the Mitochondrial DNA A2706G Polymorphism by DEL POZO, J. L, FERNANDEZ-ROS, N, SAEZ, E, HERRERO, J. I, YUSTE, J. R, BANALES, J. M

“…Mitochondrial toxicity has been recently suggested to be the underlying mechanism of long-term linezolid-associated toxicity in patients with 16S rRNA genetic…”
Get full text

Efficacy of Transjugular Intrahepatic Portosystemic Shunt to Prevent Total Portal Vein Thrombosis in Cirrhotic Patients Awaiting for Liver Transplantation by D'Avola, D, Bilbao, J.I, Zozaya, G, Pardo, F, Rotellar, F, Iñarrairaegui, M, Quiroga, J, Sangro, B, Herrero, J.I

“…Abstract Introduction Complete portal vein thrombosis (PVT) may complicate orthotopic liver transplantation (OLT), increasing its technical difficulty and the…”
Get full text

Reduction in mortality associated with secondary cytomegalovirus prophylaxis after solid organ transplantation by Serrano‐Alonso, M., Guillen‐Grima, F., Martin‐Moreno, P., Rabago, G., Manrique, J., Garcia‐del‐Barrio, M., Reina, G., Torre‐Cisneros, J., Fernandez‐Alonso, M., Herrero, J.I.

“…Background Cytomegalovirus (CMV) is the most important viral pathogen in solid organ transplant (SOT) recipients. The role of secondary CMV prophylaxis in this…”
Get full text

Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology by Berasain, C, Betés, M, Panizo, A, Ruiz, J, Herrero, J I, Civeira, M-P, Prieto, J

“…BACKGROUND The histopathological spectrum and role of hepatitis viruses in cases of hypertransaminasaemia of unknown aetiology have not been correctly analysed…”
Get full text

Subsequent Nonmelanoma Skin Cancer after Liver Transplantation by Herrero, J.I, España, A, D'Avola, D, Pardo, F, Iñarrairaegui, M, Rotellar, F, Sangro, B, Quiroga, J

“…Abstract Background Liver transplant recipients have a high risk of developing nonmelanoma skin cancer (NMSC). Some develop multiple NMSC. Methods Patients…”
Get full text

Efficacy of Laparoscopic Approach in the Management of Early Liver Transplant Complications by Pedano, N, Rotellar, F, Alvarez-Cienfuegos, J, Arredondo, J, Bellver, M, Martínez, P, Sánchez, C, Martí, P, Zozaya, G, Herrero, J.I, Pardo, F

“…Abstract The use of the laparoscopic approach in managing early liver transplant complications has been shown to be safe and feasible in various settings with…”
Get full text

Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin by Buti, M., Tabernero, D., Mas, A., Homs, M., Prieto, M., Rodríguez-Frías, F., Casafont, F., Casillas, R., González, A., Miras, M., Herrero, J.I., Castells, L., Esteban, R.

“…Aims To investigate an optimal long‐term prophylactic strategy for prevention of hepatitis B virus (HBV) recurrence after liver transplantation, we conducted a…”
Get full text

Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Patients Undergoing Liver Transplantation: A Spanish Matched Cohort Multicenter Study by Sapisochin, G, de Lope, C Rodríguez, Gastaca, M, de Urbina, J Ortiz, López-Andujar, R, Palacios, F, Ramos, E, Fabregat, J, Castroagudín, J F, Varo, E, Pons, J A, Parrilla, P, González-Diéguez, M L, Rodriguez, M, Otero, A, Vazquez, M A, Zozaya, G, Herrero, J I, Antolin, G Sanchez, Perez, B, Ciria, R, Rufian, S, Fundora, Y, Ferron, J A, Guiberteau, A, Blanco, G, Varona, M A, Barrera, M A, Suarez, M A, Santoyo, J, Bruix, J, Charco, R

“…OBJECTIVE:To evaluate the outcome of patients with hepatocellular-cholangiocarcinoma (HCC-CC) or intrahepatic cholangiocarcinoma (I-CC) on pathological…”
Get full text

Gastrointestinal Complications in Liver Transplant Recipients: MITOS Study by Herrero, J.I, Benlloch, S, Bernardos, A, Bilbao, I, Castells, L, Castroagudin, J.F, González, L, Irastorza, I, Navasa, M, Otero, A, Pons, J.A, Rimola, A, Suárez, F, Casanovas, T, Otero, E, Rodríguez, M, Serrano, T, Otero, S, López, I, Miras, M, Prieto, M

“…Abstract Introduction Liver transplant recipients frequently suffer gastrointestinal (GI) complications but their prevalence and their influence on quality of…”
Get full text

“Very Early” Intrahepatic Cholangiocarcinoma in Cirrhotic Patients: Should Liver Transplantation Be Reconsidered in These Patients? by Sapisochin, G., Rodríguez de Lope, C., Gastaca, M., Ortiz de Urbina, J., Suarez, M. A., Santoyo, J., Castroagudín, J. F., Varo, E., López‐Andujar, R., Palacios, F., Sanchez Antolín, G., Perez, B., Guiberteau, A., Blanco, G., González‐Diéguez, M. L., Rodriguez, M., Varona, M. A., Barrera, M. A., Fundora, Y., Ferron, J. A., Ramos, E., Fabregat, J., Ciria, R., Rufian, S., Otero, A., Vazquez, M. A., Pons, J. A., Parrilla, P., Zozaya, G., Herrero, J. I., Charco, R., Bruix, J.

“…A retrospective cohort multicenter study was conducted to analyze the risk factors for tumor recurrence after liver transplantation (LT) in cirrhotic patients…”
Get full text

Applicability of Living Donor Liver Transplantation in a Program of Adult Liver Transplantation by Herrero, J.I, Pardo, F, Rotellar, F, Martí, P, Zozaya, G, Alegre, F, D'Avola, D, Quiroga, J

“…Abstract Introduction The aim of this study was to investigate the applicability of living donor liver transplantation in a program of adult liver…”
Get full text

Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma by Iñarrairaegui, M, Pardo, F, Bilbao, J.I, Rotellar, F, Benito, A, D'Avola, D, Herrero, J.I, Rodriguez, M, Martí, P, Zozaya, G, Dominguez, I, Quiroga, J, Sangro, B

“…Abstract Background Occasionally, patients with hepatocellular carcinoma (HCC) who receive radioembolization with palliative intent are downstaged for radical…”
Get full text

Toxic hepatitis following sequential treatment with cotrimoxazol, levofloxacin, doxycycline and sertraline in a patient with a respiratory infection by García-Aparicio, J, Herrero-Herrero, J I

Get full text

Study on the Efficacy and Safety of Adefovir Dipivoxil Treatment in Post–Liver Transplant Patients With Hepatitis B Virus Infection and Lamivudine-Resistant Hepatitis B Virus by Bárcena, R., Del Campo, S., Moraleda, G., Casanovas, T., Prieto, M., Buti, M., Moreno, J.M., Cuervas, V., Fraga, E., De la Mata, M., Otero, A., Delgado, M., Loinaz, C., Barrios, C., Dieguez, M.L.G., Mas, A., Sousa, J.M., Herrero, J.I., Muñoz, R., Avilés, J.F., Gonzalez, A., Rueda, M.

“…Hepatitis B virus (HBV) recurrence and de novo HBV infection are frequent events in liver transplantation recipients. Treatment with lamivudine is initially…”
Get full text

Immunophenotypic Pattern of De Novo Malignancy After Liver Transplantation by González, J.P., Zabaleta, A., Sangro, P., Basualdo, J.E., Burgos, L., Paiva, B., Herrero, J.I.

“…Long-term survival after liver transplantation is affected by de novo neoplasia. The incidence of this type of malignancy is increased in the setting of…”
Get full text

Evaluation of ciprofloxacin and doxycycline in the treatment of Mediterranean spotted fever by BELTRAN, R. R, HERRERO, J. L. H

“…A comparison was made of the results obtained with ciprofloxacin (750 mg/12 h) and doxycycline (100 mg/12 h), both administered p.o. for one week, in 34 and 36…”
Get full text

Risk factors for recurrence of hepatitis C after liver transplantation by Herrero, J. Ignacio, Peña, Andrés de, Quiroga, Jorge, Sangro, Bruno, Garcia, Nicolás, Sola, Iosu, Cienfuegos, Javier A., Civeira, Maria P., Prieto, Jesús

“…Recurrent hepatitis C is a frequent complication after liver transplantation for hepatitis C virus–related cirrhosis, but risk factors related to its…”
Get full text

Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort by Sanchez Antolin, G, Testillano, M, Pascasio, J.M, Narvaez Rodriguez, I, Prieto, M, Otero, A, Herrero, J.I, Londoño, M, Fernandez Vazquez, I, Castells, L

“…Abstract Background Patients with hepatitis C virus (HCV) genotype 4 infection are poorly represented in clinical trials of 2nd-generation direct-acting…”
Get full text

Is Liver Biopsy Necessary in the Evaluation of a Living Donor for Liver Transplantation? by Herrero, J.I, Rotellar, F, Benito, A, Sola, I, D’Avola, D, Marti, P, Zozaya, G, Iñarrairaegui, M, Pardo, F

“…Abstract Background The role of liver biopsy in the evaluation of a candidate for living liver donation is controversial. Some authors suggest doing it…”
Get full text